Artelo Biosciences
ARTL
6 hedge funds and large institutions have $78.4K invested in Artelo Biosciences in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 0.09% → 0.08% (-0.02%)
14% less funds holding
Funds holding: 7 → 6 (-1)
29% less capital invested
Capital invested by funds: $111K → $78.4K (-$32.4K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.09K |
| 2 |
JP Morgan Chase
New York
|
+$620 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
-$13.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5.52K |
| 3 |
CFD
Creative Financial Designs
Kokomo,
Indiana
|
-$167 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Two Sigma Advisers
New York
| $40.9K | -$13.6K | -373 | -25% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $27.6K | – | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $9.26K | +$1.09K | +30 | +13% |
|
|
4
JP Morgan Chase
New York
| $611 | +$620 | +17 | New |
|
5
Morgan Stanley
New York
| $40 | – | – | – |
|
6
Wells Fargo
San Francisco,
California
| $38 | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$5.52K | -132 | Closed |
|
|
CFD
8
Creative Financial Designs
Kokomo,
Indiana
| – | -$167 | -4 | Closed |
|
ARTL Hedge Fund Activity: Q2 2023 in Review
6 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q2 2023, worth a combined $78.4K — down 29% from $111K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ARTL and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $1.09K. The largest seller was Two Sigma Advisers, cutting an estimated $13.6K.
- 6 institutional investors held Artelo Biosciences (ARTL) as of Q2 2023, down from 7 in Q1 2023.
- Funds reported $78.4K of Artelo Biosciences stock for Q2 2023, down 29% quarter-over-quarter.
- 1 fund opened new Artelo Biosciences positions in Q2 2023 and 2 closed out, a net change of -1 holder.
- The largest Artelo Biosciences buyer in Q2 2023 was Tower Research Capital (TRC), an estimated $1.09K added.
- The largest Artelo Biosciences seller in Q2 2023 was Two Sigma Advisers, an estimated $13.6K sold.
Based on aggregated 13F filings for Q2 2023.